+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Arthritis Drug"

US Rheumatoid Arthritis Therapeutics Market - Product Thumbnail Image

US Rheumatoid Arthritis Therapeutics Market

  • Report
  • October 2025
  • 89 Pages
  • United States
From
Psoriatic Arthritis (PSA) Treatment Market - Product Thumbnail Image

Psoriatic Arthritis (PSA) Treatment Market

  • Report
  • October 2025
  • 96 Pages
  • Global
From
Arthritis Treatment Drugs Markets in China - Product Thumbnail Image

Arthritis Treatment Drugs Markets in China

  • Report
  • August 2024
  • 238 Pages
  • China
From
From
Market Spotlight: Gout - Product Thumbnail Image

Market Spotlight: Gout

  • Report
  • January 2021
  • 38 Pages
  • Global
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
From
From
Loading Indicator

The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease. The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more